Original Article

Metabolism of lipoproteins containing apolipoprotein B in hepatic lipase-deficient mice

Correspondence to: Richard J. Havel.

Mice lacking hepatic lipase have been reported to express mild hyperlipidemia characterized by increased concentrations of large high density lipoproteins, but normal concentrations of lipoproteins containing apolipoprotein B. Whereas hepatic lipase has been implicated in the clearance and processing of chylomicron remnants in rats, no such defect was found in these mice. We have further characterized the abnormal lipoprotein phenotype in young hepatic lipase-deficient mice and have found more pronounced elevations of high density lipoproteins associated in particular with a 5-fold increase in plasma concentrations of apolipoprotein E. In addition, there was a reduction in the concentration of low density lipoproteins containing apolipoprotein B -100 and B -48 relative to precursor lipoproteins of lower density and a pronounced deficiency of apolipoprotein B -containing low density lipoproteins with density exceeding 1.029 g/mL. Conversion of radiolabeled rabbit intermediate density lipoproteins to low density lipoproteins was reduced by 6 -fold as compared with wild-type mice. Although clearance of cholesteryl ester-labeled chylomicrons from the blood was unimpaired in the deficient mice, that of chylomicron remnants was reduced. Furthermore, endocytosis of chylomicron cholesteryl esters into liver cells occurred more rapidly than in wild-type mice. The unimpaired hepatic clearance of injected chylomicron particles in hepatic lipase-deficient mice may be the result of greater acquisition of apoE from high density lipoproteins during remnant formation.

These studies thus demonstrate a critical role for mouse hepatic lipase in the formation of small, dense low density lipoproteins, as well as participation in the normal clearance and processing of chylomicron remnants.—Qiu, S., N. Bergeron, L. Kotite, R. M. Krauss, A. Bensadoun, and R. J. Havel. Metabolism of lipoproteins containing apolipoprotein B in hepatic lipase-deficient mice. J. Lipid. Res. 1998. 39: 1661–1668.

Supplementary key words: apolipoprotein B -100, apolipoprotein B -48, apolipoprotein E, chylomicron remnants, intermediate density lipoproteins, low density lipoprotein size

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S.-J. Lee, S. Kadambi, K. C-W. Yu, C. David, S. Azhar, A. D. Cooper, and S. Y. Choi Removal of chylomicron remnants in transgenic mice overexpressing normal and membrane-anchored hepatic lipase J. Lipid Res., January 1, 2005; 46(1): 27 - 35. [Abstract] [Full Text] [PDF]

				H. Gonzalez-Navarro, Z. Nong, M. J. A. Amar, R. D. Shamburek, J. Najib-Fruchart, B. J. Paigen, H. B. Brewer Jr., and S. Santamarina-Fojo The Ligand-binding Function of Hepatic Lipase Modulates the Development of Atherosclerosis in Transgenic Mice J. Biol. Chem., October 29, 2004; 279(44): 45312 - 45321. [Abstract] [Full Text] [PDF]

				S. Santamarina-Fojo, H. Gonzalez-Navarro, L. Freeman, E. Wagner, and Z. Nong Hepatic Lipase, Lipoprotein Metabolism, and Atherogenesis Arterioscler. Thromb. Vasc. Biol., October 1, 2004; 24(10): 1750 - 1754. [Abstract] [Full Text] [PDF]

				M. Verges, A. Bensadoun, J. Herz, J. D. Belcher, and R. J. Havel Endocytosis of Hepatic Lipase and Lipoprotein Lipase into Rat Liver Hepatocytes in Vivo Is Mediated by the Low Density Lipoprotein Receptor-related Protein J. Biol. Chem., March 5, 2004; 279(10): 9030 - 9036. [Abstract] [Full Text] [PDF]

				M. Rizzo, J. M. Taylor, C. M. Barbagallo, K. Berneis, P. J. Blanche, and R. M. Krauss Effects on Lipoprotein Subclasses of Combined Expression of Human Hepatic Lipase and Human apoB in Transgenic Rabbits Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 141 - 146. [Abstract] [Full Text] [PDF]

				R. J Havel Genetic underpinnings of LDL size and density: a role for hepatic lipase? Am. J. Clinical Nutrition, June 1, 2000; 71(6): 1390 - 1391. [Full Text] [PDF]

				H. Allayee, K. M. Dominguez, B. E. Aouizerat, R. M. Krauss, J. I. Rotter, J. Lu, R. M. Cantor, T. W. A. de Bruin, and A. J. Lusis Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia J. Lipid Res., February 1, 2000; 41(2): 245 - 252. [Abstract] [Full Text]

				R. A. Sendak, D. E. Berryman, G. Gellman, K. Melford, and A. Bensadoun Binding of hepatic lipase to heparin: identification of specific heparin-binding residues in two distinct positive charge clusters J. Lipid Res., February 1, 2000; 41(2): 260 - 268. [Abstract] [Full Text]

				N. Bergeron, L. Kotite, M. Verges, P. Blanche, R. L. Hamilton, R. M. Krauss, A. Bensadoun, and R. J. Havel Lamellar lipoproteins uniquely contribute to hyperlipidemia in mice doubly deficient in apolipoprotein E and hepatic lipase PNAS, December 22, 1998; 95(26): 15647 - 15652. [Abstract] [Full Text] [PDF]